Combination therapy for ovarian cancer
AssigneeEli Lilly and Company
InventorsEdward Michael Chan, Susan Elizabeth Pratt, Louis Frank Stancato
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating ovarian cancer in a mammal in need of such treatment comprising administering an effective amount of a combination of gemcitabine, cisplatin or carboplatin, and 5-[2-tert-butyl-5-(4-fluoro-phenyl)-1H-imidazol-4-yl]-3-(2,2-dimethyl-propyl)-3H-imidazo[4,5-b]pyridin-2-ylamine.
Claims10
A method of treating ovarian cancer in a mammal comprising administering to said mammal a combination of gemcitabine, a platinum agent selected from the group consisting of cisplatin and carboplatin, and 5-[2-tert-butyl-5-(4-fluoro-phenyl)-1H-imidazol-4-yl]-3-(2,2-dimethyl-propyl)-3H-imidazo[4,5-b]pyridin-2-ylamine or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.